Article Details
Retrieved on: 2021-05-27 07:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The prominent players strengthening the IgG4 related Disease pipeline include Viela Bio/Horizon Therapeutics, Xencor, Principia Biopharma, and ...
Article found on: www.bignewsnetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here